Nobivac NXT HCP

RSS

Authorised

This medicine is authorised for use in the European Union

felid herpesvirus 1, strain G2620A, live / feline calicivirus, strain F9, live / feline panleucopenia virus, strain MW-1, live
MedicineVeterinaryAuthorised

Finnish is available via eTranslation, the European Commission's machine translation service.

Translate to Finnish | Important information about machine translation

  • Application under evaluation
  • CVMP opinion
  • European Commission decision

Overview

Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website

Product details

Name of medicine
Nobivac NXT HCP
Active substance
  • felid herpesvirus 1, strain G2620A, Live
  • feline calicivirus (FCV), strain F9, live
  • feline panleucopenia virus (FPL), strain MW-1, live
International non-proprietary name (INN) or common name
  • felid herpesvirus 1, strain G2620A, live
  • feline calicivirus, strain F9, live
  • feline panleucopenia virus, strain MW-1, live

Pharmacotherapeutic group

  • Live viral vaccines
  • Immunologicals for felidae
  • feline panleucopenia virus / parvovirus + feline rhinotracheitis virus + feline calicivirus

Authorisation details

EMA product number
EMEA/V/C/006681

Assessment history

CVMP summary of positive opinion for Nobivac NXT HCP

Adopted

English (EN) (135.45 KB - PDF)

Julkaistu ensimmäisen kerran:
Näytä
This page was last updated on

Share this page